Terms: = Uterine cancer AND ARID1B, 6A3-5, 57492, ENSG00000049618, p250R, KIAA1235, ELD/OSA1, DAN15, BRIGHT, BAF250b AND Treatment
18 results:
1. Diffusion-weighted imaging as a potential non-gadolinium alternative for immediate assessing the hyperacute outcome of MRgFUS ablation for uterine fibroids.
Huang Y; Zhou S; Su Y; Pang Z; Cai S
Sci Rep; 2024 Apr; 14(1):9857. PubMed ID: 38684835
[TBL] [Abstract] [Full Text] [Related]
2. Estimating risk of endometrial malignancy and other intracavitary uterine pathology in women without abnormal uterine bleeding using IETA-1 multinomial regression model: validation study.
Heremans R; Wynants L; Valentin L; Leone FPG; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Van den Bosch T;
Ultrasound Obstet Gynecol; 2024 Apr; 63(4):556-563. PubMed ID: 37927006
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/arid1b co-inactivated dedifferentiated endometrial carcinoma.
Wong NKY; Llaurado Fernandez M; Kommoss FKF; Praveen Kumar P; Kim H; Liu J; Zhang G; Coatham M; Lin YY; Haegert AM; Volik S; Le Bihan S; Collins CC; Fu Y; Postovit LM; von Deimling A; Wu R; Xue H; Wang Y; Köbel M; Carey MS; Lee CH
Gynecol Oncol; 2023 Sep; 176():162-172. PubMed ID: 37556934
[TBL] [Abstract] [Full Text] [Related]
4. TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma.
Shi K; Liu XL; Guo Q; Zhang YQ; Fan ST; Dai L; Jiang N; Li D
PLoS One; 2023; 18(7):e0285817. PubMed ID: 37478120
[TBL] [Abstract] [Full Text] [Related]
5. Ultrasound features of endometrial pathology in women without abnormal uterine bleeding: results from the International Endometrial Tumor Analysis study (IETA3).
Heremans R; Van Den Bosch T; Valentin L; Wynants L; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Leone FPG;
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):243-255. PubMed ID: 35385178
[TBL] [Abstract] [Full Text] [Related]
6. Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis.
Solorzano-Ibarra F; Alejandre-Gonzalez AG; Ortiz-Lazareno PC; Bastidas-Ramirez BE; Zepeda-Moreno A; Tellez-Bañuelos MC; Banu N; Carrillo-Garibaldi OJ; Chavira-Alvarado A; Bueno-Topete MR; Del Toro-Arreola S; Haramati J
Clin Exp Immunol; 2021 Apr; 204(1):78-95. PubMed ID: 33306195
[TBL] [Abstract] [Full Text] [Related]
7. How noninvasive treatment of uterine fibroids affects endometrial receptivity: a prospective cohort study.
Melkozerova O; Shchedrina I; Gryshkina A; Bashmakova N; Malgina G; Michelson A; Chistyakova G
Gynecol Endocrinol; 2020; 36(sup1):28-32. PubMed ID: 33305668
[TBL] [Abstract] [Full Text] [Related]
8. [Preliminary study of the clinical value of colposcopy in diagnosing vagina invasion in cervical cancer].
Zhu YL; Zhang WH; Liu BB; Zhang P; Zhang J; Wang L
Zhonghua Fu Chan Ke Za Zhi; 2020 May; 55(5):322-326. PubMed ID: 32464720
[No Abstract] [Full Text] [Related]
9. Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the uterine Cervix.
Xing D; Zheng G; Schoolmeester JK; Li Z; Pallavajjala A; Haley L; Conner MG; Vang R; Hung CF; Wu TC; Ronnett BM
Am J Surg Pathol; 2018 Jun; 42(6):750-760. PubMed ID: 29505425
[TBL] [Abstract] [Full Text] [Related]
10. Selection and identification of novel peptides specifically targeting human cervical cancer.
Liu X; Peng J; He J; Li Q; Zhou J; Liang X; Tang S
Amino Acids; 2018 May; 50(5):577-592. PubMed ID: 29435721
[TBL] [Abstract] [Full Text] [Related]
11. uterine fibroids: correlations between MRI appearance and stiffness via magnetic resonance elastography.
Jondal DE; Wang J; Chen J; Gorny KR; Felmlee J; Hesly G; Laughlin-Tommaso S; Stewart EA; Ehman R; Woodrum DA
Abdom Radiol (NY); 2018 Jun; 43(6):1456-1463. PubMed ID: 28952003
[TBL] [Abstract] [Full Text] [Related]
12. Ending cervical cancer: A call to action.
Aranda S; Berkley S; Cowal S; Dybul M; Evans T; Iversen K; Moeti M; Osotimehin B; Peterson S; Piot P; Purandare CN; Sidibé M; Trimble T; Tsu VD
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():4-6. PubMed ID: 28691327
[TBL] [Abstract] [Full Text] [Related]
13. Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.
Mirkovic J; Sholl LM; Garcia E; Lindeman N; MacConaill L; Hirsch M; Dal Cin P; Gorman M; Barletta JA; Nucci MR; McCluggage WG; Howitt BE
Mod Pathol; 2015 Nov; 28(11):1504-14. PubMed ID: 26336887
[TBL] [Abstract] [Full Text] [Related]
14. Incidence of additional treatments in women treated with MR-guided focused US for symptomatic uterine fibroids: review of 138 patients with an average follow-up of 2.8 years.
Gorny KR; Borah BJ; Brown DL; Woodrum DA; Stewart EA; Hesley GK
J Vasc Interv Radiol; 2014 Oct; 25(10):1506-12. PubMed ID: 24998103
[TBL] [Abstract] [Full Text] [Related]
15. Signal characteristics of tumors shown by high-resolution endorectal coil magnetic resonance imaging may predict outcome among patients with cervical carcinoma treated with irradiation. A preliminary study.
Corn BW; Schnall MD; Milestone B; King S; Hauck W; Solin LJ
Cancer; 1996 Dec; 78(12):2535-42. PubMed ID: 8952562
[TBL] [Abstract] [Full Text] [Related]
16. Vaginal probe ultrasound in malignancy involving the uterine cervix.
Prefontaine M; Demianczuk N
Eur J Gynaecol Oncol; 1993; 14(6):455-60. PubMed ID: 8181484
[TBL] [Abstract] [Full Text] [Related]
17. [Endometrial carcinoma treated by radiotherapy alone].
Sun JH
Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):375-7. PubMed ID: 1782852
[TBL] [Abstract] [Full Text] [Related]
18. [Electron microscopic and immunological studies concerning the effect on the antitumor activity of sizofiran (SPG) combined with radiotherapy for cervical cancer].
Hasegawa K; Nishimura R; Kinugasa M; Okamura M; Kimura A; Ohtsu F; Takeuchi K; Mizuhira V
Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2549-61. PubMed ID: 2124607
[TBL] [Abstract] [Full Text] [Related]
